Skip to main content

Table 5 Total direct and indirect out-of-pocket costs accrued by patients with advanced NSCLC and their caregivers by disease stage

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

  Patients Caregivers
Mean annual cost outcome Stage IIIB (n = 119) Stage IV
(n = 911)
Stage IIIB (n = 30) Stage IV
(n = 397)
Total direct and indirect out-of-pocket costs (unadjusted) n = 51
€3528
n = 471
€5925
n = 19
€2232
n = 185
€4319
Financial support received from government n = 110
€737
n = 879
€2282
n = 29
€663
n = 357
€726
Total direct and indirect out-of-pocket costs (adjusteda) n = 50
€2548
n = 468
€2654
n = 18
€2241
n = 176
€3603
  1. NSCLC non-small cell lung cancer
  2. aAdjusted for financial support provided by the respective governments